Publications

Payoux, P., Remy, P., Damier, P., Miloudi, M., Loubinoux, I., Pidoux, B., Gaura, V., Rascol, O., Samson, Y. & Agid, Y. (2004). Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Archives of neurology, 61(8), 1307-13. doi:10.1001/archneur.61.8.1307

Peschanski, M., Bachoud-Levi, A. & Hantraye, P. (2004). Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. Brain : a journal of neurology, 127(Pt 6), 1219-28. doi:10.1093/brain/awh145

Peterson, M., De Gelder, B., Rapcsak, S., Gerhardstein, P. & Bachoud-Levi, A. (2000). Object memory effects on figure assignment: conscious object recognition is not necessary or sufficient. Vision Research, 40, 1549-1567. doi:10.1016/S0042-6989(00)00053-5

Pini, L., Sambatoro, F., Youssov, K., Bachoud-Levi, A., Vallesi, A. & Jacquemot, C. (2020). Striatal connectivity in premanifest Huntington disease is differentially affected by disease burden. European Journal of Neurology, 27(11), 2147-2157. doi:10.1111/ene.14423

Pini, L., Jacquemot, C., Cagnin, A., Meneghello, F., Semenza, C., Mantini, D. & Vallesi, A. (2020). Aberrant brain network connectivity in presymptomatic and manifest Huntington's disease: A systematic review. Human Brain Mapping, 1(14), 256-269. doi:10.1002/hbm.24790

Ramus, F., Peperkamp, S., Christophe, A., Jacquemot, C., Kouider, S. & Dupoux, E. (2010). A Psycholinguistic Perspective on the Acquisition of Phonology. In C. Fougeron (Eds.), Laboratory Phonology (Vol. 10 ).De Gruyter Mouton

Reilmann, R., McGarry, A. , Grachev, I. , Savola, J. , Borowsky, B., Eyal, E. , Gross, N. , Langbehn, D., Schubert, R. , Wickenberg, A. , Papapetropoulos, S. , Hayden, M. , Squitieri, F., Kieburtz, K. , Landwehrmeyer, G., European Huntington'S Disease, N. & Bachoud-Levi, A. (2019). Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study. The Lancet, Neurology, 18(2), 165-176 . doi:10.1016/S1474-4422(18)30391-0

Reinhard, C., Bachoud-Levi, A., Bäumer, T., Bertini, E., Brunelle, A., Buizer, A., Federico, A., Gasser, T., Groeschel, S., Hermanns, S., Klockgether, T., Krägeloh-Mann, I., Landwehrmeyer, G., Leber, I., Macaya, A., Mariotti, C., Meissner, W., Molnar, M. , Nonnekes, J., Ortigoza Escobar, J. , Pérez Dueñas, B., Renna Linton, L., Schöls, L., Schuele, R., Tijssen, M., Vandenberghe, R., Volkmer, A., Wolf, N. & Graessner, H. (2021). The European Reference Network for Rare Neurological Diseases. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.616569

Remy, P. & Samson, Y. (2003). The role of dopamine in cognition: evidence from functional imaging studies. Current opinion in neurology, 16 Suppl 2, S37-41.

Remy, P., Doder, M., Lees, A., Turjanski, N. & Brooks, D. (2005). Decrease of dopamine and noradrenaline innervation in the limbic system of depressed Parkinson’s disease patients. Brain(128 ), 1314-1322

Remy, P., Zilbovicius, M., Degos, J., Bachoud-Levi, A., Rancurel, G., Cesaro, P. & Samson, Y. (1999). Somatosensory cortical activations are suppressed in patients with tactile extinction: a PET study. Neurology. doi:10.1212/wnl.52.3.571

Riad, R., Bachoud-Levi, A., Rudzicz , F. & Dupoux, E. (2020). Identification of primary and collateral tracks in stuttered speech. , Vol. Proceedings of The 12th Language Resources and Evaluation Conference: In LREC, European Language Resources Association, 1681–1688.

Ribeiro, M., Thobois, S., Lohmann, E., Du Montcel, S., Lesage, S., Pelissolo, A., Dubois, B., Mallet, L., Pollak, P., Agid, Y., Broussolle, E., Brice, A., Remy, P. & French Parkinson'S Disease Genetics Study, G. (2009). A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 50(8), 1244-50. doi:10.2967/jnumed.109.063529

Ribeiro, M., Idbaih, A., Thomas, C., Remy, P., Martin-Duverneuil, N., Samson, Y., Donadieu, J. & Hoang-Xuan, K. (2008). 18F-FDG PET in neurodegenerative Langerhans cell histiocytosis : results and potential interest for an early diagnosis of the disease. Journal of neurology, 255(4), 575-80. doi:10.1007/s00415-008-0751-8

Rieu, D., Bachoud-Levi, A., Laurent, A., Jurion, E. & Dalla Barba , G. (2006). [French adaptation of the Hopkins Verbal Learning Test] Revue neurologique. doi:10.1016/s0035-3787(06)75069-x

Robotham, L., Sauter, D., Bachoud-Levi, A. & Trinkler, I. (2011). The impairment of emotion recognition in Huntington's disease extends to positive emotions. Cortex; a journal devoted to the study of the nervous system and behavior, 47(7), 880-4. doi:10.1016/j.cortex.2011.02.014

Rosser, A. & Bachoud-Levi, A. (2012). Clinical trials of neural transplantation in Huntington's disease. Progress in brain research, 200, 345-71. doi:10.1016/B978-0-444-59575-1.00016-8

Salameh , P., Farah, R., Hallit , S., Zeidan , R., Chahine, M., Asmar , R. & Hosseini, H. (2018). Self-reported history of stroke and long-term living conditions near air pollution sources: results of a national epidemiological study in Lebanon. Environ Monit Assess, 190(3), 153. doi:10.1007/s10661-018-6545-2

Saleh, N., Moutereau, S., Azulay, J., Verny, C., Simonin, C., Tranchant, C., El Hawajri, N., Bachoud-Levi, A. & Maison, P. (2010). High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology. doi:10.1212/WNL.0b013e3181e62076

Saleh, N., Moutereau, S., Durr, A., Krystkowiak, P., Azulay, J., Tranchant, C., Broussolle, E., Morin, F., Bachoud-Levi, A. & Maison, P. (2009). Neuroendocrine disturbances in Huntington's disease. PloS one, 4(3), e4962. doi:10.1371/journal.pone.0004962

Salem, L., Saleh, N., Désaméricq, G., Youssov, K., Dolbeau, G., Cleret de Langavant, L., Bourhis, M., Azulay, J., Krystkowiak, P., Verny, C., Morin, F., Moutereau, S., French Huntington Study, G., Bachoud-Levi, A. & Maison, P. (2016). Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease. PloS one, 11(9), e0162890. doi:10.1371/journal.pone.0162890

Salem, L., Saleh, N., Youssov, K., Olivier, A., Charles, P., Scherer, C., Verny, C., Bachoud-Levi, A. & Maison, P. (2014). The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials. Fundamental & clinical pharmacology, 28(6), 700-10. doi:10.1111/fcp.12077

Sambin, S., Teichmann, M., De Diego Balaguer, R., Giavazzi, M., Sportiche, D., Schlenker, P. & Bachoud-Levi, A. (2012). The role of the striatum in sentence processing: disentangling syntax from working memory in Huntington's disease. Neuropsychologia, 50(11), 2625-35. doi:10.1016/j.neuropsychologia.2012.07.014

Scharenborg, O., Besacier, L., Black, A., Hasegawa-Johnson, M., Metze, F., Neubig, G., Stuker, S., Godard, P., Muller, M., Ondel, L., Palaskar, S., Arthur, P., Ciannella, F., Du, M., Larsen, E., Merkx, D., Riad, R., Wang, L. & Dupoux, E. (2018). Linguistic Unit Discovery From Multi-Modal Inputs In Unwritten Languages: Summary Of The “Speaking Rosetta” Jsalt 2017 Workshop. In Jsalt 2017 Workshop.

Schramm, C., Bachoud-Levi, A. & Katsahian, S. (2018). Clustering of longitudinal data by using an extended baseline: A new method for treatment efficacy clustering in longitudinal data. Stat Methods Med Res, 27(1), 97-113. doi:10.1177/0962280215621591

Schramm, C., Katsahian, S., Youssov, K., Démonet, J., Krystkowiak, P., Supiot, F., Verny, C., Cleret de Langavant, L. & Bachoud-Levi, A. (2015). How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease. PLoS ONE. doi:10.1371/journal.pone.0145842

Schramm, C., Vial, C., Bachoud-Levi, A. & Katsahian, S. (2015). Clustering of longitudinal data by using an extended baseline: A new method for treatment efficacy clustering in longitudinal data. Statistical methods in medical research, 27(1), 97-113. doi:10.1177/0962280215621591

Seddik, L. , Faugeras, F., Abdelhedi, J. , Hosseini, H. & Bachoud-Levi, A. (2019). Quand ça va dans tous les sens : opsoclonus sans myoclonus. Revue Neurologique, 175(1), S24. doi:10.1016/j.neurol.2019.01.091

Segaux, L., Oubaya, N., Leissing-Desprez, C., Cleret de Langavant, L., Broussier, A., Fromentin, I., David, J. & Bastuji-Garin, S. (2021). Plus d’un tiers des personnes âgées de 50 à 65 ans souffrent de troubles cognitifs non repérés. Revue d'Épidémiologie et de Santé Publique, 69(1), S39-S40. doi:10.1016/j.respe.2021.04.063

Shin, M., Jan, C., Jacquard, C., Jarraya, B., Callebert, J., Launay, J., Hantraye, P., Remy, P., Palfi, S. & Brouillet, E. (2011). Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration. Neurobiology of aging, 32(11), 2100-2. doi:10.1016/j.neurobiolaging.2009.11.015